While a wave of stock market enthusiasm in the United States for biotech company flotations has yet to cross the Atlantic, venture capital appetite for promising European companies is returning.
Biotech is hot on Wall Street, with the Nasdaq sector index up 43 percent this year, listed U.S. stocks scaling all-time highs and roughly 23 biotech companies going public.
Image Courtesy of renjith krishnan / FreeDigitalPhotos.net
To read the original article: Venture capital warms to European biotechs - chicagotribune.com
